An unusual recurrent high-grade glioneuronal tumor with MAP2K1 mutation and CDKN2A/B homozygous deletion

• Barry Cheaney,
• Stephen Bowden,
• Katie Krause,
• Emily A. Sloan,
• Arie Perry,
• David A. Solomon,
• Seunggu Jude Han,
• Matthew D. Wood

Affiliations

Barry Cheaney

School of Medicine, Oregon Health & Science University

Stephen Bowden

Department of Neurological Surgery, Oregon Health & Science University

Katie Krause

Department of Neurological Surgery, Oregon Health & Science University

Emily A. Sloan

Department of Pathology, University of California San Francisco

Arie Perry

Department of Pathology, University of California San Francisco

David A. Solomon

Department of Pathology, University of California San Francisco

Seunggu Jude Han

Department of Neurological Surgery, Oregon Health & Science University

Matthew D. Wood

Department of Pathology, Oregon Health & Science University